Ambev S.A. $ABEV Shares Acquired by Quantbot Technologies LP

Quantbot Technologies LP boosted its stake in Ambev S.A. (NYSE:ABEV) by 577.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 427,221 shares of the company’s stock after buying an additional 364,165 shares during the period. Quantbot Technologies LP’s holdings in Ambev were worth $953,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CANADA LIFE ASSURANCE Co grew its stake in shares of Ambev by 74.8% in the second quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock valued at $32,624,000 after buying an additional 5,740,155 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Ambev by 12.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company’s stock worth $80,410,000 after acquiring an additional 3,864,844 shares in the last quarter. Marshall Wace LLP raised its stake in shares of Ambev by 192.7% in the second quarter. Marshall Wace LLP now owns 4,208,299 shares of the company’s stock valued at $10,142,000 after acquiring an additional 2,770,698 shares in the last quarter. Bank of America Corp DE raised its position in Ambev by 9.9% in the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock valued at $66,288,000 after purchasing an additional 2,479,310 shares in the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC increased its stake in shares of Ambev by 12,937.7% during the second quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,385,900 shares of the company’s stock worth $5,750,000 after buying an additional 2,367,600 shares during the period. Hedge funds and other institutional investors own 8.13% of the company’s stock.

Ambev Stock Up 0.3%

Shares of Ambev stock opened at $2.93 on Friday. The company has a market cap of $46.17 billion, a P/E ratio of 16.28, a PEG ratio of 2.15 and a beta of 0.64. The firm has a fifty day moving average of $2.83 and a two-hundred day moving average of $2.51. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96. Ambev S.A. has a one year low of $2.10 and a one year high of $3.24.

Ambev (NYSE:ABEV) last posted its quarterly earnings results on Thursday, February 12th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05. The firm had revenue of $4.50 billion during the quarter, compared to analysts’ expectations of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. On average, analysts forecast that Ambev S.A. will post 0.18 earnings per share for the current year.

Ambev Announces Dividend

The firm also recently disclosed a special dividend, which was paid on Friday, January 9th. Investors of record on Monday, December 22nd were issued a dividend of $0.049 per share. This represents a yield of 1,465.0%. The ex-dividend date of this dividend was Monday, December 22nd. Ambev’s dividend payout ratio is currently 183.33%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ABEV. Sanford C. Bernstein restated a “market perform” rating and issued a $2.88 price objective on shares of Ambev in a report on Wednesday, November 26th. Weiss Ratings raised Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday. Wall Street Zen raised shares of Ambev from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Finally, Barclays raised their price objective on Ambev from $2.50 to $3.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 17th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $2.69.

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.